Moderna
MRNA
#1163
Rank
ยฃ12.96 B
Marketcap
ยฃ33.69
Share price
-3.68%
Change (1 day)
-46.43%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: ยฃ12.96 Billion

As of December 2024 Moderna has a market cap of ยฃ12.96 Billion. This makes Moderna the world's 1163th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024ยฃ12.96 B-56.44%
2023ยฃ29.76 B-47.82%
2022ยฃ57.03 B-25.23%
2021ยฃ76.28 B151.54%
2020ยฃ30.32 B504.16%
2019ยฃ5.01 B26.92%
2018ยฃ3.95 B

End of Day market cap according to different sources

On Dec 2nd, 2024 the market cap of Moderna was reported to be:

ยฃ13.56 Billion
by Yahoo Finance info icon info icon
ยฃ13.56 Billion
by CompaniesMarketCap info icon info icon
ยฃ13.46 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ยฃ84.11 M-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ204.30 B 1,475.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.65 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ25.59 B 97.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ166.87 B 1,187.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ2.64 B-79.57%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ292.10 B 2,152.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.35 B-81.85%๐Ÿ‡บ๐Ÿ‡ธ USA